Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
코로나19로 입원한 환자에서 토실리주맙의 효능
Randomized Controlled Trial
[키워드] 95% CI
95% confidence interval
acute respiratory syndrome
analyses
assigned
baseline
benefit
blockade
body temperature
comparison
confidence interval
coronavirus
coronavirus disease
death
disease
double-blind
effective
Efficacy
enrolled
Fever
greater
hazard ratio
Hispanic
hospitalized patient
Hyperinflammatory
Infection
interleukin-6 receptor
intubation
Latino
maintain
mechanical ventilation
median age
median time
men
outcome
oxygen saturation
Patient
performed
Placebo
placebo-controlled trial
Primary outcome
pulmonary infiltrates
Randomized
Randomly
receive
receiving
SARS-CoV-2
serious infection
single dose
standard care
supplemental oxygen
the patient
the placebo group
time-to-event analysis
Tocilizumab
women
worsening
[DOI] 10.1056/NEJMoa2028836 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1056/NEJMoa2028836 PMC 바로가기 [Article Type] Randomized Controlled Trial